Table of contents

Details Overview Explorer Related

Cancer Clinical Trial Eligibility Criteria: Performance Status Guidance for Industry, IRBs, and Clinical Investigators

FDA-2024-D-1377-0016Other

Comments

0

Awaiting comments

Deadline

--

Net supporti

—

Document

Details

The document's own metadata, straight from the source system.

Title: Cancer Clinical Trial Eligibility Criteria: Performance Status Guidance for Industry, IRBs, and Clinical Investigators

Posted: Jul 28, 2026
Comment period: Jul 28, 2026 – ?
Agency: Food and Drug Administration (FDA)
Topics: Biomedical Research

View on regulations.gov ↗

Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.